Past Podcast Episodes

When Pierluigi Mantovani saw what was available to help his father rehabilitate his MS-related foot drop, he was motivated to invent something better. Pierluigi recruited a couple of friends and their efforts led to a breakthrough solution for foot drop that was declared the winner of the Lyfebulb and Bristol Myers Squibb Addressing Unmet Needs in MS: Innovation Challenge.

Pierluigi joins me as my guest this week to discuss EvoWalk, his award-winning example of innovation in MS rehabilitation.

Pierluigi Montovani

We'll also share some very unsettling realities about MS treatment that have been revealed in the latest addition to the MS International Federation's Atlas of MS.

We're checking in with an exercise coach and one of the participants in the STEP for MS trial. You'll hear about this participant's remarkable progress and we'll tell you how you can still participate in this study.

We'll tell you about a new Yale University study that's designed to determine whether Ocrevus can prevent the onset of MS in people diagnosed with radiologically isolated syndrome.

And although the oral disease-modifying therapy Ozanimod (Zeposia) has already been approved to treat relapsing-remitting MS in the U.S., Canada, and Europe, we'll update you on the decision not to approve it for use in England and Wales.

We have a lot to talk about! Are you ready for RealTalk MS??!

Atlas of MS, Part 2 Reveals Some Unsettling Truths 2:19

Zeposia fails to win approval by NICE 6:10

The Step for MS Study with Brendon Truax and Bo Roberts 8:15

Yale study will test whether Ocrevus can prevent MS in patients diagnosed with RIS 14:23

Pierluigi Mantovani discusses his father's inspiration in developing EvoWalk for rehabilitating MS foot drop 16:49

Share this episode 27:44

Have a minute? Leave a rating & review for the podcast 28:05

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/194

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS

Introducing EvoWalk

Atlas of MS

STUDY: Prevention of Clinical Multiple Sclerosis in Individuals with Radiologically Isolated Disease

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 194
Guests: Brendon Truax, Bo Roberts, and Pierluigi Montovani

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

The COVID-19 pandemic has created what experts are calling a mental health crisis of unparalleled proportion. Many people affected by MS have had to add pandemic-related stresses and anxieties to the already existing anxieties that come from living with a chronic illness. And that's a lot to carry around every day.

Joining me to talk about managing your mood and quieting some of the noise in your head is psychologist, psychoanalyst, Certified Multiple Sclerosis Specialist, and MS Partner in Care, Dr. Gayle Lewis.

We're also talking about the initial findings of the COVER-MS study, which is looking at how the COVID-19 vaccines are affecting people living with MS.

We're inviting all MS care partners to participate in a short survey designed to measure their awareness of patient-focused drug development as well as their interest in adding their unique perspective to this work.

We'll tell you about OCTOPUS, a revolutionary progressive MS clinical trial that is designed to be a game-changer when it comes to MS clinical trials.

And we'll share the details and tell you where and how to register for this month's CAN-DO MS programs.

We have a lot to talk about! Are you ready for RealTalk MS??!

Initial findings of the COVER-MS study 1:43

Announcing the Care Partners in Patient-Focused Drug Development Survey 4:28

Introducing OCTOPUS, a revolutionary progressive MS clinical trial 5:57

CAN-DO MS May Programs 8:13

Dr. Gayle Lewis discusses emerging from the trauma of the pandemic 10:00

Share this episode 36:55

Have a minute? Leave a rating & review for the podcast 37:19

SHARE THIS EPISODE OF REALTALK MS

Just copy this link and paste it into your text or email: https://realtalkms.com/193

ADD YOUR VOICE TO THE CONVERSATION

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS

Dr. Gayle Lewis MS Teletherapy

STUDY: COVER-MS Initial Findings: Side Effects

Participate in the COVER-MS study

Patient-Focused Drug Development for Care Partners Survey

CAN-DO MS Programs

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 193
Guests: Dr. Gayle Lewis